Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04063592 · ClinicalTrials.gov registry record · NA
AMI Construction in Lower Extremity Residual Limbs
A NA study of Amputation, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 3
- Study locations
NCT04063592: Recruiting NA study of Amputation, sponsored by Brigham and Women's Hospital.
NCT04063592 is a NA study of Amputation that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 26 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04063592, a NA study of Amputation, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will involve the development of a novel approach to lower extremity residual limb surgical revision that offers the promise of augmenting volitional motor control, restore proprioception and reverse atrophy
Primary Outcome
Clinical examination and images from CT/MRI will be combined to construct a holistic view of the morphology of the residual limb. Imaging studies and limb measurements taken in clinic will also be used to measure muscle atrophy/hypertrophy over time.
Conditions Studied
Interventions
- PROCEDURE Residual limb revision
Study Locations (3)
Massachusetts
- Brigham and Women's Hospital - Boston
- Massachusetts Institute of Technology - Cambridge
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT04063592 shows while recruiting
NCT04063592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Residual limb revision is the first listed.
NCT04063592 reports a single indexed study location in Massachusetts, Maryland.
Frequently Asked Questions
What is clinical trial NCT04063592 about?
NCT04063592 is a clinical study titled "AMI Construction in Lower Extremity Residual Limbs". This study will involve the development of a novel approach to lower extremity residual limb surgical revision that offers the promise of augmenting volitional motor control, restore proprioception and reverse atrophy
What is the current status of trial NCT04063592?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2020-02-24. Estimated completion is 2026-09-30.
What conditions does trial NCT04063592 study?
This clinical trial studies the following conditions: Amputation.
What interventions are being tested in trial NCT04063592?
The interventions under investigation include: Residual limb revision (PROCEDURE).
Who is sponsoring clinical trial NCT04063592?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04063592 being conducted?
This trial has 3 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04063592's enrollment target sits among peer trials
26 30th of 65 higher than 35 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
- NCT04913064 · 26 participants · NA
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI